2m 2m 2m 2m 2m 2m 2m
INMUNE BIO-AI (INMB)
NASDAQ
$1.87+$0.005 (+0.27%)
Price as of Jul 14, 2026 8:16 AM EDT- $49.4MMarket Cap
- -12.26%1-Year Change
- BiotechnologyIndustry
INMUNE BIO-AI (INMB)
$1.87+$0.005 (+0.27%)
INMB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.86 | ||
Change | -$0.08 (-4.12%) | ||
Open | $1.88 | ||
High | $1.99 | ||
Low | $1.81 | ||
Previous Close | $1.94 | ||
Volume | 1,077,821 | ||
30-Day Average Volume | 1,502,110 | ||
1-Week Change | 11.71% | ||
1-Month Change | 50.00% | ||
1-Year Change | -12.26% | ||
3-Year Change | -81.12% | ||
5-Year Change | -93.03% | ||
Fundamentals | |||
Shares Outstanding | 26.6M | ||
Total Assets | $25.8M | ||
Market Cap | $49.4M | ||
Enterprise Value | $28.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$5.4M | ||
Free Cash Flow | -$3.4M | ||
EBIT | -$5.4M | ||
EBITDA | -$5.3M | ||
Net Working Capital | $17.4M | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -9 | ||
PEG | -5 | ||
Price/Free Cash Flow | -15 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue